Sustainable and cost-effective monitoring of patients on ART

by Diana M Gibb, Peter Mugyenyi
Published 2014-01-01

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts

by Francis Bajunirwe, Flora Tumwebaze, Denis Akakimpa, Cissy Kityo, Peter Mugyenyi, George Abongomera
Published 2018-01-01

Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda.

by Steven Baveewo, Francis Ssali, Charles Karamagi, Joan N Kalyango, Judith A Hahn, Kenneth Ekoru, Peter Mugyenyi, Elly Katabira
Published 2011-01-01

Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda.

by Elvin H Geng, Mwebesa B Bwana, Jerome Kabakyenga, Winnie Muyindike, Nneka I Emenyonu, Nicholas Musinguzi, Peter Mugyenyi, Jeffrey N Martin, David R Bangsberg
Published 2010-11-01

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the...

by Cissy Kityo, Diana M Gibb, Charles F Gilks, Ruth L Goodall, Ivan Mambule, Pontiano Kaleebu, Deenan Pillay, Ronnie Kasirye, Peter Mugyenyi, A Sarah Walker, David T Dunn, DART Trial Team
Published 2014-01-01

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.

by Charles F Gilks, A Sarah Walker, Paula Munderi, Cissy Kityo, Andrew Reid, Elly Katabira, Ruth L Goodall, Heiner Grosskurth, Peter Mugyenyi, James Hakim, Diana M Gibb, DART Virology Group and Trial Team
Published 2013-01-01

A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.

by Steven J Reynolds, Cissy Kityo, Claire W Hallahan, Geoffrey Kabuye, Diana Atwiine, Frank Mbamanya, Francis Ssali, Robin Dewar, Marybeth Daucher, Richard T Davey, Peter Mugyenyi, Anthony S Fauci, Thomas C Quinn, Mark R Dybul
Published 2010-04-01

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries

by Richard M. Gibson, Gabrielle Nickel, Michael Crawford, Fred Kyeyune, Colin Venner, Immaculate Nankya, Eva Nabulime, Emmanuel Ndashimye, Art F. Y. Poon, Robert A. Salata, Cissy Kityo, Peter Mugyenyi, Miguel E. Quiñones-Mateu, Eric J. Arts
Published 2017-12-01

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa

by Colin M. Venner, Immaculate Nankya, Fred Kyeyune, Korey Demers, Cynthia Kwok, Pai-Lien Chen, Sandra Rwambuya, Marshall Munjoma, Tsungai Chipato, Josaphat Byamugisha, Barbara Van Der Pol, Peter Mugyenyi, Robert A. Salata, Charles S. Morrison, Eric J. Arts
Published 2016-11-01

Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection.

by Katja Klein, Gabrielle Nickel, Immaculate Nankya, Fred Kyeyune, Korey Demers, Emmanuel Ndashimye, Cynthia Kwok, Pai-Lien Chen, Sandra Rwambuya, Art Poon, Marshall Munjoma, Tsungai Chipato, Josaphat Byamugisha, Peter Mugyenyi, Robert A Salata, Charles S Morrison, Eric J Arts
Published 2018-01-01

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study

by T. Sonia Boender, Kim C. E. Sigaloff, Joshua Kayiwa, Victor Musiime, Job C. J. Calis, Raph L. Hamers, Lillian Katumba Nakatudde, Elizabeth Khauda, Andrew Mukuye, James Ditai, Sibyl P. Geelen, Peter Mugyenyi, Tobias F. Rinke de Wit, Cissy Kityo
Published 2012-01-01

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.

by Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E Mujica Mota, A Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M Gibb, Charles F Gilks, DART Trial Team
Published 2012-01-01

Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial

by Robert Gross, MD MSCE, Justin Ritz, MS, Michael D Hughes, ProfPhD, Robert Salata, ProfMD, Peter Mugyenyi, ProfFRCPE, Evelyn Hogg, BA, Linda Wieclaw, BA, Catherine Godfrey, MD, Carole L Wallis, PhD, John W Mellors, ProfMD, Victor O Mudhune, MPH, Sharlaa Badal-Faesen, MBBCh, Beatriz Grinsztejn, ProfMD, Ann C Collier, ProfMD
Published 2019-05-01